Amylin's long-delayed diabetes drug gets US nod
Amylin Pharmaceuticals won approval Friday for its long-delayed diabetes drug Bydureon, a next-generation treatment that requires fewer injections than the company's 7-year old diabetes medicine, Byetta.
Go to Source
Click Here To Check Out This what can diabetics eat Solution
Related posts:
- Amylin's long-delayed diabetes drug gets US nod
- Amylin's long-delayed diabetes drug gets US nod
- Amylin's long-delayed diabetes drug gets US nod
- Amylin's long-delayed diabetes drug gets FDA nod
- Amylin's long-delayed diabetes drug gets FDA nod
Tags: US
Leave a comment
Featured Resources
Free Diabetic Guide
Follow us on Twitter
- An error has occurred; the feed is probably down. Try again later.
Random Search Terms
- oral thrush wont go away
- how does the development of diabetes directly related to the breakdown of a feedback system
- what is the implied population? solutions
- can diabetics take oxyelite pro
- oxyelite pro/type 1 diabetes
- why does sugar give me a headache
- Can you take oxyelite pro and glucophage
- 520-463-7481
- does meps test for diabetes
- diabetes and thursh
Tags
ADD Additional Details ADHD ALWAYS American Diabetes Association Celiac Disease Diabetes Care DM Dreamfields Pasta Drug Administration ECG ED England EXTREMELY FAU FDA GD Gestational Diabetes Harvard Medical School HELP HIV India Joslin Diabetes Center Juvenile Diabetes LOT MEPS MS NASA New York NHS NOBODY Open Question Paula Deen Paul Garland PCOS POLL REALLY Resolved Question Stop Diabetes UK United States US USA UTI Wales